Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19.

ABSTRACT:

Purpose

The role of angiotensin receptor blockers (ARB), angiotensin-converting enzyme inhibitors (ACEi), or other antihypertensive agents in the case of Covid-19 remains controversial. We aimed to investigate the association between antihypertensive agent exposure and in-hospital mortality in patients with Covid-19.

Methods

We performed a retrospective multicenter cohort study on patients hospitalized between February 1 and May 15, 2020. All patients had been followed up for at least 30 days.

Results

Of the 8078 hospitalized patients for Covid-19, 3686 (45.6%) had hypertension and were included in the study. In this population, the median age was 75.4 (IQR, 21.5) years and 57.1% were male. Overall in-hospital 30-day mortality was 23.1%. The main antihypertensive phar

SUBMITTER: Chouchana L 

PROVIDER: S-EPMC7887412 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature